XML 34 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Related Parties
 3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Related Parties Related Parties
The Company’s significant transactions with its related parties are primarily comprised of revenue generating activities under collaboration and license agreements.
Significant related party transactions included in the condensed consolidated balance sheet, excluding the Company’s investments and equity method investments, are summarized below (in thousands):
As of March 31, 2025As of December 31, 2024
Deferred revenue, current and non-current:
Allonnia$36,472 $36,495 
Arcaea28,413 28,413 
BiomEdit— 7,583 
Genomatica290 564 
Ayana Bio2 — 
 $65,177 $73,055 
Significant related party transactions included in the condensed consolidated statements of operations and comprehensive loss, excluding the losses on the Company’s investments and equity method investments, are summarized below (in thousands):
Three Months Ended March 31,
20252024
Cell Engineering revenue:
Genomatica$274 $369 
Ayana Bio240 147 
Allonnia1 59 
Motif— 19 
BiomEdit7,583 — 
Other equity investees— 139 
$8,098 $733